The FDA breast-implant patient decision checklist explained
The FDA-required breast-implant checklist is product-specific labeling reviewed before surgery, not a generic form or guarantee. The prospective patient initials it, and both patient and implanting physician sign it. Keep the checklist with the booklet, boxed warning, consent, operative report, and device card.
The FDA breast-implant patient decision checklist is part of the labeling for the exact implant being considered, not a substitute for consultation or informed consent. It is reviewed before surgery; the prospective patient initials its sections, and the patient and implanting physician sign it. Preserve the completed checklist with the manufacturer booklet, boxed warning, consent, operative report, and device card.123
The checklist creates a structured discussion and a durable record. It does not certify that an implant is right for a particular person, prove that every question was answered well, or predict an individual outcome.
Put each document in its proper place
| Document | Primary job | What it does not replace |
|---|---|---|
| Patient booklet or brochure | Product-specific description, risks, studies, expected follow-up and manufacturer information | A personalized clinical discussion |
| Boxed warning | Prominent summary of major limitations and risks | The full labeling and checklist |
| Patient decision checklist | Structured review and acknowledgment of defined topics before implantation | Informed consent or permission obtained under pressure |
| Informed-consent form | Procedure-, patient-, surgeon-, facility- and alternative-specific consent record | The manufacturer's implant labeling |
| Patient device card | Post-surgery identification of the implants actually placed | The preoperative decision record or complete operative report |
FDA restricted the sale and distribution of breast implants to help ensure that prospective patients receive required risk information. Current labeling includes a boxed warning and patient decision checklist that must be reviewed with the patient; the checklist is initialed and signed, including the implanting physician’s signature.23
Match the checklist to the planned product
Start with manufacturer, product family, fill, shell surface, shape, profile or projection, size range, and approval record. Open the current manufacturer labeling through FDA’s approved-implant page rather than using an undated PDF forwarded without context.4
Compare the checklist version and booklet with the exact device under discussion. If the plan changes—from saline to silicone, smooth to another surface, or one product family to another—ask what labeling changes and whether the checklist should be reviewed again. The saline-versus-silicone guide can organize fill differences, but it does not replace the product’s own label.
Read the initials as prompts, not a speed test
FDA’s example checklist covers reasons someone may not be a candidate, risks of breast-implant surgery, BIA-ALCL, systemic symptoms, long-term effects, alternatives, and confirmation that specific materials were received.3 A clinic should leave room to translate each item into the proposed operation.
For every section, ask:
- Which statement applies to the exact implant and which applies to surgery generally?
- What uncertainty or frequency does the current labeling report?
- How does the proposed incision, pocket, fill, surface, reconstruction or augmentation context change the discussion?
- What surveillance or follow-up is expected?
- Which symptoms or changes have a defined contact path?
- What additional operation or imaging costs are outside the original quote?
The replacement-timing guide explains why “not a lifetime device” is not a mandatory ten-year exchange date. The MRI-versus-ultrasound guide separates silent-rupture screening from diagnostic imaging and breast-cancer screening.
Reconcile the planned implant with the implanted device
After surgery, FDA tells patients to receive a device card with information on each specific implant.1 Compare it with the operative report, stickers, bill, and preoperative plan. The UDI and device-card guide explains device identifier, model, lot, and serial fields without mistaking registration for approval or warranty enrollment.
A complete personal packet can include:
- the dated manufacturer booklet and completed checklist;
- signed informed consent;
- surgeon, facility and anesthesia identities;
- operative report and implant log;
- device card and implant stickers;
- current surveillance plan;
- manufacturer registration or warranty confirmation, if chosen; and
- contact details for symptoms, imaging questions, recalls, and later surgery.
Use the checklist to improve the consultation
- Identify the candidate implant. Capture manufacturer, product family, fill, surface, shape, dimensions, and FDA approval record.
- Get current labeling early. Obtain the exact patient booklet, boxed warning, and checklist before the operative deadline.
- Annotate questions. Mark unclear terms, product-specific risks, alternatives, surveillance, additional procedures, and cost ownership.
- Review with the implanting physician. Connect each checklist item to the proposed person, implant, operation, facility, and follow-up plan.
- Preserve the signed version. Keep a complete copy rather than only a signature page or portal acknowledgment.
- Close the record after surgery. Match the device card and operative record to what was planned, and retain updated manufacturer information.
The decisive question is: “Can I match the completed checklist, current manufacturer labeling, consent, operative record, and device card to the exact implants being considered and ultimately placed?”
Sources
- U.S. Food and Drug Administration. Breast Implant Surgery. Used for consultation timing, product-specific patient labeling, checklist review, consent, and device-card expectations. Accessed .
- U.S. Food and Drug Administration. Things to Consider Before Getting Breast Implants. Used for FDA's sale-and-distribution restrictions and required labeling elements. Accessed .
- U.S. Food and Drug Administration. Breast Implants—Certain Labeling Recommendations to Improve Patient Communication. Used for the FDA checklist example, boxed warning, signatures, risk topics, and device-card content. Accessed .
- U.S. Food and Drug Administration. Labeling for Approved Breast Implants. Used for product-specific manufacturer labeling and current approval-record verification. Accessed .